RMSL — REMSleep Holdings Income Statement
0.000.00%
Last trade - 00:00
- $15.41m
- $14.51m
- $0.32m
2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0.321 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 0.072 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.335 | 2.34 | 0.243 | 0.426 | 1.54 |
Operating Profit | -0.335 | -2.34 | -0.243 | -0.426 | -1.22 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.413 | -3.89 | -1.18 | -3.83 | -1.49 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.413 | -3.89 | -1.18 | -3.83 | -1.49 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.413 | -3.89 | -1.18 | -3.83 | -1.49 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.413 | -3.89 | -1.18 | -3.83 | -2.02 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.092 | -0.086 | -0.006 | -0.005 | -0.001 |